Abbott Laboratories (ABT) Other financing activities (2009 - 2026)

Abbott Laboratories has disclosed Other financing activities across 18 years of filings, most recently posting $3.0 million for Q2 2026.

• In Q2 2026, Other financing activities fell 91.43% year-over-year to $3.0 million; the TTM figure through Jun 2026 stood at $193.0 million (down 56.04% YoY), while the FY2025 annual figure was $396.0 million, up 50.0% from the prior year.
• Other financing activities came in at $3.0 million for Q2 2026 at Abbott Laboratories, down from $116.0 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $287.0 million in Q1 2025 to a low of $3.0 million in Q2 2026.
• Average Other financing activities over 5 years is $61.8 million, with a median of $48.5 million recorded in 2022.
• Year-over-year, Other financing activities jumped 169.23% in 2025 and tumbled 91.43% in 2026.
• Over 5 years, Other financing activities stood at $41.0 million in 2022, then retreated by 17.07% to $34.0 million in 2023, then fell by 26.47% to $25.0 million in 2024, then sank by 80.0% to $5.0 million in 2025, then tumbled by 40.0% to $3.0 million in 2026.
• Per Business Quant data, the three most recent Other financing activities figures were $3.0 million in Q2 2026, $116.0 million in Q1 2026, and $5.0 million in Q4 2025.